Evidence map›Paper›PMID 41899107›Full record

ArticleJournal of clinical medicine2026

Genetic Variations in the M6A Modification Pathway as Potential Predictors of Imatinib Secondary Resistance in Gastrointestinal Stromal Tumors.

Baijun Zhou, Zhenchong Chen, Gengyi Zhang, Shaoxing Guan, Wei Zhuang, Min Huang, Haibo Qiu, Xueding Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The mCells · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Baijun ZhouInstitute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510080, China.
Zhenchong ChenDepartment of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Gengyi ZhangInstitute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510080, China.
Shaoxing GuanInstitute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510080, China.
Wei ZhuangDepartment of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen 361005, China.ORCID 0000-0002-1720-8882
Min HuangInstitute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510080, China.
Haibo QiuDepartment of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Xueding WangInstitute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510080, China.

Funding

Featured Clinical Technique of Guangzhou 2023P-TS24Guangdong Provincial Key Laboratory of Construction Foundation 2020B1212060034National Natural Science Foundation of China 82020108031, 82504921, 82474002, 82404752Natural Science Foundation of Guangdong Province 2022A1515012549, 2023A1515012667
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gastrointestinal stromal tumorgenetic variationimatinib mesylatem6A modificationprogression-free survivalsingle nucleotide polymorphism

Identifiers

PMID41899107
PMCPMC13027091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.